YogaWorks is executing on their national expansion strategy through the acquisitions of studios. On October 19, 2017, YogaWorks purchased seven Houston-based studios. This gives the company a presence in Texas.
On October 13, 2017, YogaWorks announced that it acquired Pure Om’s two yoga studios in Fairfax, Virginia, and Bethesda, Maryland, bringing its total studio count in the Washington, DC, area to 13.
Continue reading “YogaWorks Expanding Nationally Through Acquisitions of Studios”
Sorrento Therapeutics Inc has bounced off its 61.8 percent Fibonacci retracement level.
Continue reading “Sorrento Therapeutics Inc Bounce Off 61.8 Percent Retracement”
Verastem Inc price target was raised to $17 by Cantor Fitzgerald last week. The new $17 price target represents 330% upside from the previous close of $3.95. Cantor has a Buy rating on the stock.
Cantor Fitzgerald is respected on Wall Street but they do not have the most accurate analysts IMO. Oppenheimer Holdings Inc is a more followed analyst than Cantor Fitzgerald. It’s no surprise then that I think it’s more significant that on October 12, 2017, Oppenheimer reiterated their Buy rating on Verastem Inc stock and set a price target of $6 which represents an upside of 52% from the previous close. The $6 price target seems more down-to-earth and achievable than Cantor’s stratospheric $17 price target.
Continue reading “Verastem Inc Price Target Raised By Cantor Fitzgerald”
Transenterix stock is coming off a 50 percent retracement after the stock exploded higher from FDA approval of its Senhance Robotic Surgical System. This is the first FDA surgical robotic system approval in two decades.
Where Sehance Robotic Surgical System beats Intuitive Surgical’s da Vinci system is in the fully reusable instruments, which promises to vastly lower the per-procedure cost of robotic surgery.
Continue reading “Transenterix Stock 50 Percent Retracement After FDA Approval”
Square Inc stock is trading inside a Bull Flag pattern as analysts at Citigroup raised Square’s price target to $38 from $30 on October 18, 2017. The $38 price target represents 16.9% upside from its current price. Citigroup reiterated its Buy rating on the stock.
Continue reading “Square Inc Stock In Bullish Flag On Citigroup Price Hike”
ContraVir Pharmaceuticals stock had short covering ahead of a price target hike by Maxim Group. A new $4 price target was set by analysts at Maxim Group on Thursday, October 19, 2017, which represents a 451% upside from the previous close of $0.73. Maxim has a Buy rating on ContraVir Pharmaceuticals stock.
Continue reading “ContraVir Pharmaceuticals Short Covering On Maxim Price Hike”
A weekly Saturday night financial show that attempts to predict market direction for the week ahead by looking at a variety of technical and fundamental indicators. Included are stocks that could trend higher over the coming days and weeks driven by strong catalysts or strong fundamentals.
Continue reading “Saturday Market Prediction Show For Week of October 23 2017”
Deutsche Bank AG initates coverage of Sinclair Broadcast Group stock with a Buy rating and a price target of $46. Deutsche Bank is one of the most widely followed rating firms because of their excellent track record.
Sinclair Broadcast Group stock has 6 Buy ratings from analysts with an average price target of $48.17 which represents a 59.49% upside from the current price.
Continue reading “Deutsche Bank Gives Sinclair Broadcast Group Stock a Buy Rating”
Celanese Corporation looks like a good swing trade long setup on the chart as the company rolls out plans for its global expansion.
Continue reading “Celanese Corporation Good Chart Setup On Global Expansion Plans”